 NEW HAVEN, Conn., Nov. 13, 2020 GLOBE NEWSWIRE -- BioXcel Therapeutics, Inc. BTI or the Company Nasdaq: BTAI, a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced that Dr. Vimal Mehta, Founder and Chief Executive Officer of BTI, will participate in a fireside chat at the Jefferies Virtual London Healthcare Conference. 